Legal Opinion
Acorda Therapeutics Inc. v. Mylan Pharmaceuticals Inc.
Court of Appeals for the Federal Circuit
Decided March 18, 2016No. 2015-1456, 2015-1460PublishedCited by 53 opinions
1Opinion of the Court
Opinion for the court filed by Circuit Judge TARANTO. Opinion concurring in the judgment filed by Circuit Judge O’MALLEY.
TARANTO, Circuit Judge. ■
These appeals involve two actions brought in the District of Delaware against generic drug manufacturer Mylan Pharmaceuticals Inc. One, assigned to Chief Judge Stark, was brought by brand-name drug manufacturers Acorda Therapeutics Inc. and Alkermes Pharma Ireland Ltd.; the- other, assigned to Judge Sleet, was brought by brand-name drug manufacturer AstraZeneca AB. The plaintiffs brought the actions under 35 U.S.C. § 271(e)(2), alleging that their…
2Cases cited26 opinions
- International Shoe Co. v. WashingtonSupreme Court of the United States · 1945
- Burger King Corp. v. RudzewiczSupreme Court of the United States · 1985
- World-Wide Volkswagen Corp. v. WoodsonSupreme Court of the United States · 1980
- Daimler AG v. BaumanSupreme Court of the United States · 2014
- Walden v. FioreSupreme Court of the United States · 2014
21 more not listed; retrieve them via the Exa API.
3Cited by53 opinions
- Genuine Parts Co. v. CepecSupreme Court of Delaware · 2016
- Xilinx, Inc. v. Papst Licensing Gmbh & Co. KgCourt of Appeals for the Federal Circuit · 2017
- Regenlab U.S. LLC v. Estar Techs. Ltd.District Court, S.D. Illinois · 2018
- Galderma Labs., L.P. v. Teva Pharm. USA, Inc.District Court, N.D. Texas · 2017
- Bors v. Johnson & JohnsonDistrict Court, E.D. Pennsylvania · 2016
48 more not listed; retrieve them via the Exa API.